Available IPD datapackage for study 'Randomised, Double-blind, 56 Week Placebo-controlled, Parallel Group, Multicentre, Phase 3 Study to Evaluate the Efficacy and Safety of 2 Doses of Benralizumab in Patients With Moderate to Very Severe COPD With a History of Exacerbations'
收藏DataCite Commons2025-07-07 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00006224.0
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of the study is to determine if benralizumab reduces COPD exacerbation rate in symptomatic patients with moderate to very severe COPD who are receiving standard of care therapies
提供机构：
Vivli
创建时间：
2025-07-07
